Positive impactCompany
360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr
Economic Times 1 hr ago·7 Sept 2026, 3:26 pm
360 One Group CEO Karan Bhagat has acquired 1.3 lakh shares of Novartis India for about Rs 22 crore. This purchase was made through his investment firm, Kyrush Investments, which sold an equal number of shares in the same transaction. The move signals confidence in the company's future prospects.
This news is significant for investors as it coincides with a major strategic shift for Novartis India. The company recently announced plans to acquire trademarks from Pfizer for Rs 1,250 crore. This acquisition is expected to strengthen its portfolio in the domestic market. Additionally, Novartis AG is selling its stake to a consortium, which excludes its innovative medicines business in India.
Investors should monitor how this strategic realignment impacts Novartis India's market position and growth trajectory. The integration of Pfizer's trademarks and the focus on the non-innovative medicines segment will be key factors to watch in the coming quarters.
Excerpt from Economic Times
(What's moving Sensex and Nifty Track latest market news , stock tips , Budget 2025 , Share Market on Budget 2025 and expert advice , on ETMarkets . Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)…Read the original at Economic Times
Affected stocks
Bullish1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Novartis India (NOVARTIND).
- Category: Company.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update for Novartis India. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
